Skip to content

CNBX PHARMACEUTICALS INC.

CNBX

CIK 0001343009

← back to feed
Revenue (TTM)
$0
−100.0% YoY Q2 Apr 2026
Net Income (TTM)
−$287.33K
+54.8% YoY Q2 Apr 2026
EPS Diluted (TTM)
$0.00
+100.0% YoY Q2 Apr 2026
Gross Margin
—
Q2 Apr 2026
Operating Margin
—
Q2 Apr 2026
Net Margin
—
Q2 Apr 2026
Free Cash Flow (TTM)
—
Q2 Apr 2026
Cash
$12.15K
Q2 Apr 2026
Total Debt
$75K
Q2 Apr 2026
Shares Outstanding
1.23B sh
Q2 Apr 2026

Revenue & Net Income

EPS (Diluted)

Margins

Cash Flow

Revenue Growth (YoY)

Balance Sheet

Cash vs Debt

Recent filings